Published in Br J Clin Pharmacol on February 01, 1992
Towards the safer use of medicines. BMJ (1995) 3.50
Coroner's cases of death due to errors in prescribing or giving medicines or to adverse drug reactions: Birmingham 1986-1991. J R Soc Med (1994) 1.90
'Acceptable' risk of drug treatment. Br J Clin Pharmacol (1992) 0.75
Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28
Perception of risk. Science (1987) 17.91
Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays? Br Med J (Clin Res Ed) (1983) 1.24
Is risk assessment conservative? Science (1989) 0.91
Chemical risk assessment: a review. Vet Hum Toxicol (1989) 0.88
Medicines and risk. J Intern Med (1990) 0.88
Drug errors. A judgement of errors. Nurs Times (1991) 0.88
Health and safety risk analyses: information for better decisions. Science (1987) 0.87
Newly licensed drugs. BMJ (1996) 6.68
Medical errors. Medical schools can teach safe drug prescribing and administration. BMJ (2001) 3.53
Joining the DoTS: new approach to classifying adverse drug reactions. BMJ (2003) 3.47
Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ (2006) 3.02
Is there a cure for drug errors? BMJ (1995) 2.55
Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients. BMJ (1995) 2.36
Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Lancet (1982) 2.30
Misleading drug packaging. BMJ (1995) 2.12
'The strategy of desire' and rational prescribing. Br J Clin Pharmacol (1994) 1.84
Minocycline for acne. BMJ (1996) 1.61
Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. Br Med J (Clin Res Ed) (1987) 1.46
Why are thiazide diuretics declining in popularity? J Hum Hypertens (2001) 1.44
Lead poisoning from Asian traditional remedies in the West Midlands--report of a series of five cases. Hum Exp Toxicol (1995) 1.42
Alternative venlafaxine kinetics in overdose. J Clin Pharm Ther (2002) 1.40
Improving prescribing using a rule based prescribing system. Qual Saf Health Care (2004) 1.29
Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care (2010) 1.27
Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther (2004) 1.23
Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology (2004) 1.17
Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2007) 1.14
Adverse drug reactions: who is to know? BMJ (1993) 1.13
Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol (2001) 1.09
Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. J Med Genet (2005) 1.06
Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. Br Med J (Clin Res Ed) (1983) 1.05
Comparative tolerability profiles of oral antidiabetic agents. Drug Saf (1994) 1.03
The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs. Clin Pharmacokinet (1987) 1.01
The influence of big pharma. BMJ (2005) 1.00
The safety of spironolactone treatment in patients with heart failure. J Clin Pharm Ther (2003) 0.99
The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging (2004) 0.99
Alcohol intake: measure for measure. BMJ (2001) 0.97
Testing the practical aspects of therapeutics by objective structured clinical examination. J Clin Pharm Ther (2004) 0.97
Poisoning with anti-hypertensive drugs: calcium antagonists. J Hum Hypertens (1995) 0.96
Systemic toxicity related to metal hip prostheses. Clin Toxicol (Phila) (2014) 0.92
Anabolic steroids: the power and the glory? BMJ (1988) 0.91
Monitoring for adverse drug reactions. Br J Clin Pharmacol (2006) 0.91
Atropine treatment for baclofen overdose. Postgrad Med J (1981) 0.90
Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1. Eye (Lond) (2011) 0.89
The lacing defence: double blind study of thresholds for detecting addition of ethanol to drinks. BMJ (2000) 0.89
An analysis and comparison of commonly available United Kingdom prescribing resources. J Clin Pharm Ther (2010) 0.86
Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. J Hum Hypertens (1995) 0.86
Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care. Pharmacoepidemiol Drug Saf (2010) 0.85
Plasma exchange for Guillain-Barré syndrome. J R Soc Med (1989) 0.85
Secondary prevention in coronary heart disease. Cost effectiveness of treatment must be borne in mind. BMJ (1998) 0.83
Paracetamol elimination in patients with non-insulin dependent diabetes mellitus. Br J Clin Pharmacol (1993) 0.83
Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 0.82
Multiple lower limb non-ossifying fibromas in siblings with neurofibromatosis. Eur J Radiol (1998) 0.81
Increase in US medication-error deaths. Lancet (1998) 0.80
Effects of short-term hyperglycemia on insulin secretion in normal humans. Am J Physiol (1986) 0.80
Should doctors who make clinical errors be charged with manslaughter? A survey of medical professionals and members of the public. Med Sci Law (2008) 0.78
Persistent insulin secretion after insulin overdose in a non-diabetic patient. Lancet (1993) 0.78
Rhabdomyolysis and acute renal failure following carbon monoxide poisoning: two case reports with muscle histopathology and enzyme activities. J Toxicol Clin Toxicol (1992) 0.78
The medico-legal significance of pharmacokinetic interactions with ethanol. Med Sci Law (2012) 0.77
Republished paper: Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Postgrad Med J (2010) 0.77
Heparin-induced thrombosis. Postgrad Med J (1997) 0.77
Episodes of environmental poisoning worldwide. Occup Environ Med (2002) 0.76
Our poisoned patients. QJM (2001) 0.76
Decision support for sensible dosing in electronic prescribing systems. J Clin Pharm Ther (2011) 0.76
Severe relapsing sulphonylurea-induced hypoglycaemia: a diagnostic and therapeutic challenge. Postgrad Med J (2003) 0.76
A model for NICE in the US. BMJ (2009) 0.75
Adverse events in British hospitals. Retrospective case record analysis has been superseded. BMJ (2001) 0.75
Overdose of diltiazem. BMJ (1994) 0.75
Are images mirages? J R Soc Med (1997) 0.75
Medication errors detected in infusions. Arch Intern Med (2003) 0.75
Chemical burns causing systemic toxicity. Arch Emerg Med (1993) 0.75
Liver transplantation after paracetamol overdose. BMJ (1991) 0.75
Reducing medication errors. JAMA (2001) 0.75
The British Medical Journal and prescribing of minocycline for acne. Br J Dermatol (2013) 0.75
Lithium and pregnancy. Lancet (1992) 0.75
Pyrexia, anaemia and acute renal failure secondary to omeprazole. Postgrad Med J (1998) 0.75
Lack of effect of co-trimoxazole on the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol (1990) 0.75
Drug advertising in medical journals. Lancet (2003) 0.75
Dispensing with prescriptions. BMJ (1994) 0.75
Acute renal failure without acute intravascular haemolysis after nomifensine overdosage. Hum Toxicol (1986) 0.75
Superficial hyperglycaemia. Lancet (1985) 0.75
Mirtazepine overdose and miosis. J Toxicol Clin Toxicol (2003) 0.75
Monitoring of clozapine and norclozapine plasma concentration-time curves in acute overdose. J Toxicol Clin Toxicol (2000) 0.75
Poisoning with anti-hypertensive drugs: methyldopa and clonidine. J Hum Hypertens (1995) 0.75
Angiotensin receptor antagonists--a new class of antihypertensive drug. J Clin Pharm Ther (1996) 0.75
Fatal atheromatous embolization during coronary angiography. Cardiovasc Intervent Radiol (1982) 0.75
Poisoning with anti-hypertensive drugs: alpha-adrenoceptor antagonists. J Hum Hypertens (1995) 0.75
Diuretic therapy for hypertension: a cancer risk? J Hum Hypertens (1999) 0.75
Pericardial effusion--an uncommon complication of Salmonella enteritis. Br J Clin Pract (1993) 0.75
Time to discontinue the use of solutions A and B as a cyanide 'antidote'. Occup Med (Lond) (1994) 0.75
Acute interstitial nephritis after re-exposure to nomifensine. Hum Toxicol (1987) 0.75
A radiographic lead in lead poisoning. Hum Exp Toxicol (1994) 0.75
Outpatient preoperative assessment: the surgeon's view. Ann R Coll Surg Engl (1979) 0.75
How should we react to adverse drug reactions? Postgrad Med J (2011) 0.75
Why is there still disagreement over insulin secretion in non-insulin-dependent diabetes? Diabet Med (1986) 0.75
A focus on human toxicology. Hum Exp Toxicol (1993) 0.75
Tri-iodothyroacetic acid abuse in a female body builder. Lancet (1986) 0.75
Pleural effusion and fever in a middle-aged Asian man. Postgrad Med J (1999) 0.75
Safety of mianserin. Lancet (1988) 0.75
Charcoal-column haemoperfusion does not significantly enhance chlormethiazole removal. Hum Toxicol (1986) 0.75
Massive glibenclamide overdose without hypoglycaemia in a man with diabetes after partial pancreatectomy. Hum Toxicol (1986) 0.75
A suitable case for treatment. Lancet (1995) 0.75
Poisoning with anti-hypertensive drugs: beta-adrenoceptor blocker drugs. J Hum Hypertens (1995) 0.75
Poisoning with antihypertensive drugs: diuretics and potassium supplements. J Hum Hypertens (1995) 0.75
Acute non-oliguric renal failure secondary to sulphinpyrazone overdose. J Clin Pharm Ther (1992) 0.75
The metabolic effects of aspirin in fasting and fed subjects: relevance to the aetiology of Reye's syndrome. Eur J Clin Pharmacol (1990) 0.75